×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TMDX – transmedics group, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TMDX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
04:16 pm
tmdx
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/23
04:05 pm
tmdx
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
12/17
08:15 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.
Medium
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.
12/12
04:05 pm
tmdx
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12/11
08:21 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
12/11
08:21 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Robert W. Baird from $150.00 to $120.00. They now have an "outperform" rating on the stock.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Robert W. Baird from $150.00 to $120.00. They now have an "outperform" rating on the stock.
12/11
08:21 am
tmdx
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $110.00 to $90.00. They now have an "overweight" rating on the stock.
Low
Report
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target lowered by analysts at Piper Sandler from $110.00 to $90.00. They now have an "overweight" rating on the stock.
12/8
04:46 am
tmdx
Down Over 60%, Is TransMedics Stock a Buy on the Dip? [Yahoo! Finance]
Low
Report
Down Over 60%, Is TransMedics Stock a Buy on the Dip? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/11
06:49 pm
tmdx
Form 4 TransMedics Group, Inc. For: Dec 09 Filed by: Hernandez Gerardo
Low
Report
Form 4 TransMedics Group, Inc. For: Dec 09 Filed by: Hernandez Gerardo
12/9
04:07 pm
tmdx
Form 8-K TransMedics Group, Inc. For: Dec 05
Low
Report
Form 8-K TransMedics Group, Inc. For: Dec 05
12/6
11:39 am
tmdx
Form SCHEDULE 13G/A TransMedics Group, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A TransMedics Group, Inc. Filed by: FMR LLC
12/4
06:00 pm
tmdx
Form 4 TransMedics Group, Inc. For: Dec 02 Filed by: Khayal Tamer I
Medium
Report
Form 4 TransMedics Group, Inc. For: Dec 02 Filed by: Khayal Tamer I
12/2
04:48 pm
tmdx
Form 3 TransMedics Group, Inc. For: Dec 02 Filed by: Hernandez Gerardo
Medium
Report
Form 3 TransMedics Group, Inc. For: Dec 02 Filed by: Hernandez Gerardo
12/2
04:16 pm
tmdx
Form 8-K TransMedics Group, Inc. For: Nov 26
Medium
Report
Form 8-K TransMedics Group, Inc. For: Nov 26
11/13
04:31 pm
tmdx
Form 4 TransMedics Group, Inc. For: Nov 11 Filed by: Khayal Tamer I
Medium
Report
Form 4 TransMedics Group, Inc. For: Nov 11 Filed by: Khayal Tamer I
11/7
04:34 pm
tmdx
Form 4 TransMedics Group, Inc. For: Nov 05 Filed by: Basile Edward M
Low
Report
Form 4 TransMedics Group, Inc. For: Nov 05 Filed by: Basile Edward M
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency
25.3%
3/2 TransMedics Group, Inc. (TMDX) Q4 2019 Earnings Call Transcript [The Motley Fool] 19.5%
4/13 Form 8-K TransMedics Group, Inc. For: Apr 10 12.4%
3/17 Form 10-K TransMedics Group, Inc. For: Dec 28 12.0%
11/1 2 Hot Healthcare IPOs [The Motley Fool] 10.0%
8/22 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 7.6%
7/17 TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019 6.9%
12/12 Form 4 TransMedics Group, Inc. For: Dec 12 Filed by: KANIA EDWIN M JR 6.7%
4/14 Form DEF 14A TransMedics Group, Inc. For: Jun 04 6.4%
4/7 TransMedics Group Inc (NASDAQ: TMDX) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $25.00 price target on the stock. 4.7%
3/2 TransMedics Group, Inc. (TMDX) Q4 2019 Earnings Call Transcript [The Motley Fool] 19.5%
4/13 Form 8-K TransMedics Group, Inc. For: Apr 10 12.4%
3/17 Form 10-K TransMedics Group, Inc. For: Dec 28 12.0%
11/1 2 Hot Healthcare IPOs [The Motley Fool] 10.0%
8/22 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 7.6%
7/17 TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019 6.9%
12/12 Form 4 TransMedics Group, Inc. For: Dec 12 Filed by: KANIA EDWIN M JR 6.7%
4/14 Form DEF 14A TransMedics Group, Inc. For: Jun 04 6.4%
4/7 TransMedics Group Inc (NASDAQ: TMDX) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $25.00 price target on the stock. 4.7%
TOP News Decliners
3/14
TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.
-18.2%
11/6 TransMedics Reports Third Quarter 2019 Financial Results -10.9%
3/6 Form 4 TransMedics Group, Inc. For: Feb 27 Filed by: DAMME LAURA -10.8%
3/27 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.8%
4/14 TransMedics Group Inc (NASDAQ: TMDX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $19.00 price target on the stock. -8.7%
8/7 TransMedics Reports Second Quarter 2019 Financial Results -6.2%
2/19 TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 -4.9%
3/20 TransMedics Group Inc (NASDAQ: TMDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.8%
2/28 Form 8-K TransMedics Group, Inc. For: Feb 27 -4.7%
5/6 Form 4 TransMedics Group, Inc. For: May 06 Filed by: Lung Biotechnology PBC -4.6%
11/6 TransMedics Reports Third Quarter 2019 Financial Results -10.9%
3/6 Form 4 TransMedics Group, Inc. For: Feb 27 Filed by: DAMME LAURA -10.8%
3/27 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.8%
4/14 TransMedics Group Inc (NASDAQ: TMDX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $19.00 price target on the stock. -8.7%
8/7 TransMedics Reports Second Quarter 2019 Financial Results -6.2%
2/19 TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 -4.9%
3/20 TransMedics Group Inc (NASDAQ: TMDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.8%
2/28 Form 8-K TransMedics Group, Inc. For: Feb 27 -4.7%
5/6 Form 4 TransMedics Group, Inc. For: May 06 Filed by: Lung Biotechnology PBC -4.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: